Cysteamine Hydrochloride is an aminothiol that depletes lysosomal cystine by forming mixed disulfides, used as the definitive treatment for nephropathic cystinosis, and also used topically in dermatology for hyperpigmentation management. Simson Pharma's Cysteamine Hydrochloride reference standard and impurities support QC across these rare-disease and topical applications.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cysteamine Hydrochloride Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.